4th Quarter - Report

PURPLE ADVOCACY, LLC for DAVITA INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.

LobbyistCovered position, as disclosed
SARAH HAMLETT —
MEGHAN JOHNSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 8 (113th), H.R. 8 (113th), H.J.Res. 59 (113th)

Medicare/Medicaid MMM

End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.

LobbyistCovered position, as disclosed
SARAH HAMLETT —
MEGHAN JOHNSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 8 (113th), H.R. 8 (113th), H.J.Res. 59 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.